DJIA 17,822.07 43.92 0.25%
NASDAQ 4,772.90 24.50 0.52%
S&P 500 2,070.27 9.04 0.44%
market minute promo

GlaxoSmithKline (NYSE: GSK)

43.34 0.05 (0.12%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $43.34 0.12%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.08
Previous Close $43.29
Daily Range $42.98 - $43.58
52-Week Range $41.29 - $56.73
Market Cap $104.1B
P/E Ratio 14.88
Dividend (Yield) $2.45 (6.1%)
Ex-Dividend Date
Dividend Pay Date
11/05/14
01/08/15
Volume 3,125,156
Average Daily Volume 3,847,177
Current FY EPS $3.04

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary

3 Beaten Down Stocks Ready to Bounce Back

Not all stocks had a great 2014. Here are three stocks that could be ready for a comeback.

Strength Seen in Agenus (AGEN): Stock Soars 17.2% - Tale of the Tape

GlaxoSmithKline (GSK) Stock Rises Today on Positive Experimental Shingles Vaccine Trial Results

Complex Sino-U.S. Ties Shine In Avon, Solar And Qualcomm Cases

Vanguard FTSE Europe ETF Experiences Big Outflow

Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog

3 Reasons GlaxoSmithKline PLC Could Soar in 2015

GlaxoSmithKline shareholders have suffered through a rough year, but these three catalysts could send its stock soaring in 2015.

Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR

3 Stocks That Might Slash Their Dividends in 2015

These three companies all offer sector-beating dividend yields. But with each facing serious headwinds, can they maintain these huge yields next year?

This Tiny Biotech Worries Sanofi and Shire, and Vexes GlaxoSmithKline

Amicus Therapeutics plans to file for EU approval of a treatment for Fabry Disease that could challenge Sanofi and Shire.

See More GSK News...

GSK's Top Competitors

GSK $43.34 (0.12%)
Current stock: GSK
JNJ $105.60 (-1.13%)
Current stock: JNJ
NVS $94.57 (0.00%)
Current stock: NVS
RHHBY $34.45 (-6.64%)
Current stock: RHHBY